|
EspAddText
EspRemoveText
|
CMA Recommendations on Vaccine Equity and Intellectual Property
|
Parliamentary submission
|
2022
|
|
EspAddText
EspRemoveText
|
Health Canada consultation on Canadian drugs and substances strategy
|
Response to consultation
|
2018
|
|
EspAddText
EspRemoveText
|
Health Canada consultation on edible cannabis, extracts & topicals
|
Response to consultation
|
2019
|
|
EspAddText
EspRemoveText
|
Health Canada consultation on reducing youth access and appeal of vaping products
|
Response to consultation
|
2019
|
|
EspAddText
EspRemoveText
|
Mental Health, Mental Illness & Addiction : CMA Submission to the Standing Committee on Social affairs, Science and Technology
|
Parliamentary submission
|
2012
|
|
EspAddText
EspRemoveText
|
Policy Brief: CSAM-SMCA in Support of the Decriminalization of Drug Use and Possession for Personal Use
|
Policy endorsement
|
2021
|
|
EspAddText
EspRemoveText
|
Statement to the House of Commons Committee on Health addressing the opioid crisis in Canada
|
Parliamentary submission
|
2016
|